Hospital Universitario Nuestra Señora de Candelaria or University Hospital of the Nuestra Señora de Candelaria is a large teaching hospital of general scope in Tenerife. Located in the city of Santa Cruz de Tenerife. Affiliated with the Servicio Canario de la Salud.

There are 960 beds in Hospital Universitario Nuestra Señora de Candelaria.

During the past decade, Hospital Universitario Nuestra Señora de Candelaria conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 20 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 9 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Nuestra Señora de Candelaria" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Spanish Breast Cancer Research Group" with 9 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Fundación GECP" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Nuestra Señora de Candelaria" #1 collaborator was "Asociación Científica Pulmón y Ventilación Mecánica" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Nuestra Señora de Candelaria" are "Breast Cancer" (7 trials), "Breast Neoplasms" (3 trials), "Colorectal Cancer" (3 trials), "Multiple Myeloma" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Hospital Universitario Nuestra Señora de Candelaria" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Nuestra Señora de Candelaria" are "Drug" (41 trials), "Device" (14 trials), "Other" (8 trials), "Procedure" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (5 trials), "Placebo" (4 trials), "Capecitabine" (3 trials), "Cyclophosphamide" (3 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Nuestra Señora de Candelaria" are 71 trials for "All" genders, 14 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Nuestra Señora de Candelaria". 2 are not yet recruiting, 20 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Hospital Universitario Nuestra Señora de Candelaria, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Nuestra Señora de Candelaria, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".